on Bausch Health Companies Inc. (NASDAQ:BHC)
Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025
Bausch Health Companies Inc. has announced the launch of Solta Medical's Fraxel FTX™, the next generation of skin resurfacing technology. Debuting at the American Society for Laser Medicine & Surgery 2025 Annual Conference, this latest advancement promises to enhance treatments in skin rejuvenation, targeting sun damage, wrinkles, acne scars, and pigmentation issues. Designed for precision, efficiency, and comfort, Fraxel FTX™ offers dermatologists and aesthetic professionals a cutting-edge tool to achieve noticeable results.
The Fraxel FTX™ system features a dual wavelength fractional laser for treating superficial and deep skin layers, a redesigned ergonomic handpiece, and an intelligent optical tracking system, promising minimal downtime for patients. Bausch Health aims to set a new standard in laser skin resurfacing, enhancing patient care and satisfaction. Plans are underway to expand the product's availability globally in the coming months.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bausch Health Companies Inc. news